Geetha Kandasamy,1 Dalia Almaghaslah,1 Mona Almanasef,1 Tahani Musleh Almeleebia,1 Khalid Orayj,1 Ayesha Siddiqua,1 Eman Shorog,1 Asma M Alshahrani,1 Kousalya Prabahar,2 Vinoth Prabhu Veeramani,2 Palanisamy Amirthalingam,2 Saleh Alqifari,2 Naif Alshahrani,3 Aram Hamad AlSaedi,4 Alhanouf A Alsaab,5 Fatimah Aljohani,6 M Yasmin Begum,7 Akhtar Atiya8

1Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia; 2Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Kingdom of Saudi Arabia; 3Department of Pharmacy, Ad Diriyah Hospital, Ministry of Health (MOH), Riyadh, 13717, Kingdom of Saudi Arabia; 4College of Medicine, Taibah University, Al Madinah Al Munawwarah, Saudi Arabia; 5Pharmacist at Abha International Private Hospital, Abha, Saudi Arabia; 6Pharmacist at Prince Sultan Armed Forces Hospital, Almadenah Almonwarah, Saudi Arabia; 7Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia; 8Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia

Correspondence: Geetha Kandasamy, Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia, Email [email protected]

View the original paper by Dr Kandasamy and colleagues

This is in response to the Letter to the Editor

We appreciate Ulayya et al for their interest on our recently published paper entitled “A Study of the effect of treatment on the clinical profile, pain, and disability in migraine patients seen in a tertiary hospital”.1 While the authors’ feedback and suggestions were greatly appreciated, we would like to highlight a number of points.2 First, information on ethical clearance was indicated in the published paper under the methodology section. Specifically, the study received ethics approval from the Institutional Review Board of a multispecialty hospital in India. The ethics approval certificate was provided along with the manuscript at the time of submission. Second, we would like to acknowledge that the study was conducted in South India. However, the name of the hospital was deliberately left unspecified in order to maintain institutional confidentiality. The paper indicates that the study was conducted in a multispecialty hospital in India to provide some context while safeguarding confidentiality. Including the specific location of the study sample will be ensured in our future publications. Lastly, in our study, we mentioned that all types of migraine were assessed thoroughly by a neurologist. This encompasses migraine with aura, migraine without aura, and chronic migraine, which diagnosed based on the International Classification of Headache Disorders (ICHD-3) criteria.3

In conclusion, we are greatly thankful to the editor for giving us the chance to respond to Ulayya et al concerns, we are sincerely grateful to the authors for their constructive feedback and insightful views.

The authors have disclosed that there are no conflicts of interest in this communication.

1. Kandasamy G, Almaghaslah D, Almanasef M, et al. A study of the effect of treatment on the clinical profile, pain, and disability in migraine patients seen in a tertiary hospital. J Multidiscip Health. 2024;17:3525–483534. doi:10.2147/JMDH.S471216

2. Ulayya A, Azzahra A, Sari N. Response to article “A study of the effect of treatment on the clinical profile, pain, and disability in migraine patients seen in a tertiary hospital. J Multidiscip Health. 2024;17:3773–3774. doi:10.2147/jmdh.s488339

3. The international classification of headache disorders. Available from: https://ichd-3.org/Lastaccessed:11.27.2020. Accessed July15, 2024.

© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.